# Enhancing Nutrition and Antenatal Infection Treatment for Maternal and Child Health in Ethiopia

> **NCT04171388** · PHASE4 · WITHDRAWN · sponsor: **Brigham and Women's Hospital**

## Conditions studied

- Low Birthweight
- Preterm Birth
- Maternal; Malnutrition, Affecting Fetus
- Sexually Transmitted Diseases
- Urinary Tract Infections
- Pregnancy and Infectious Disease

## Interventions

- **DRUG:** Azithromycin 500 mg
- **DIETARY_SUPPLEMENT:** Multiple Micronutrient or Fortified Balanced Energy Protein Supplement
- **DRUG:** Placebo oral tablet 500 mg
- **OTHER:** Enhanced Infection Management Package (EIMP)

## Key facts

- **NCT ID:** NCT04171388
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-03-01
- **Primary completion:** 2021-05-28
- **Final completion:** 2021-11-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Trial withdrawn due to COVID-19.
- **Last updated:** 2020-08-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04171388

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04171388, "Enhancing Nutrition and Antenatal Infection Treatment for Maternal and Child Health in Ethiopia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04171388. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*